Comparison of Overall Function Between Postpartum Women With and Without Diastasis Rectus Abdominis (DRA)

January 23, 2023 updated by: Texas Woman's University
The purpose of this research is to examine the effects of diastasis rectus abdominis on the overall function of postpartum women and to determine test-retest reliability and construct validity of a self-assessment palpation of inter-rectus distance for DRA using telehealth.

Study Overview

Detailed Description

Step 1: Recruitment

  • The investigators will place recruitment fliers in local obstetrician offices, labor and delivery units in local hospitals, retail and daycare establishments, and on social media outlets such as Facebook, Instagram and Twitter.
  • The recruitment fliers will ask interested women to email a student investigator to enroll in the research project.

Step 2: Collection of functional outcome data using a Qualtrics version of the Inventory of Functional Status After Childbirth (IFSAC), a demographic survey, a numeric pain reporting scale, Oswestry Low Back Pain Disability Questionnaire, and the Pelvic Floor Distress Index.

Step 3: A meeting time will be set up with every participant to conduct a telehealth visit with a research assistant. During this virtual visit on a private, password protected Zoom call the participant will be instructed on self-assessment palpation of the abdominal wall in order to determine the presence or absence of diastasis rectus abdominis (DRA) along the inter-rectus distance (IRD).

Step 4: The first 18 participants with self-assessed DRA and the first 18 participants without self-assessed DRA, who live in Wichita or surrounding areas, will be scheduled for a one-time in-person confirmation appointment. The appointment will last a maximum of 15 minutes and occur at the WSU Old Town campus room A106. During this confirmation appointment research assistants will screen the participant with the COVID Pre-screening Questions Tool, obtain written informed consent, check the participant in, collect height and weight, and the principal investigator will measure the participants abdominal wall using real-time ultrasound, measure the IRD using the PI's palpation method, and ask the participant to demonstrate and measure IRD using the same palpation method used on the telehealth visit. See the virus protection plan for details of which all participants and investigators will follow in order to minimize risks related to COVID-19).

Step 5: The data will be entered into SPSS and analyzed with appropriate statistical analyses.

Study Type

Observational

Enrollment (Anticipated)

150

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Kansas
      • Wichita, Kansas, United States, 67260
        • Recruiting
        • Wichita State University
        • Contact:
        • Principal Investigator:
          • Jennifer Celso, DPT
        • Sub-Investigator:
          • Brooke Schutte
        • Sub-Investigator:
          • Amanda Goebel
        • Sub-Investigator:
          • Shayna Karmann
        • Sub-Investigator:
          • Sterling Pray
        • Sub-Investigator:
          • Samantha Reif
        • Sub-Investigator:
          • Shelby Davis
        • Sub-Investigator:
          • Michaela Gerhard
        • Sub-Investigator:
          • B'Aylana Morgan
        • Sub-Investigator:
          • Alexandria Rausch
        • Sub-Investigator:
          • Haylie Schmidt
        • Sub-Investigator:
          • Madelyn Hayes
        • Sub-Investigator:
          • Madisyn Keller
        • Sub-Investigator:
          • Peyton Price
        • Sub-Investigator:
          • Ashley Zane
        • Sub-Investigator:
          • Lauren Zwiesler
        • Sub-Investigator:
          • Sharon Wang-Price, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

The investigators will place recruitment fliers in local obstetrician offices, labor and delivery units in local hospitals, retail and daycare establishments, and on social media outlets such as Facebook, Instagram and Twitter. An announcement will also be included in the Wichita State University Shocker Blast and Strategic Communications. The recruitment fliers will ask interested women to email a research assistant to enroll in the research project.

Description

Inclusion Criteria:

  • Women ages 18-40 years
  • Postpartum (within 6-10 weeks of vaginal delivery)

Exclusion Criteria:

  • Women who are currently being treated by a physical therapist for their diastasis rectus abdominis
  • Women who had high-risk pregnancies (bedrest, gestational diabetes, pregnancy-induced hypertension)
  • Women with a history of abdominal or back surgery
  • Women with history of connective tissue disease such as Ehlers-Danlos Syndrome

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Postpartum Women WITH DRA
Participants who have the diagnosis of diastasis rectus abdominis
This will be used to determine if the participant has the diagnosis
This will be used in a subgroup of participants to confirm/rule out a diagnosis
Postpartum Women WITHOUT DRA
Participants who do not have a diagnosis of diastasis rectus abdominis
This will be used to determine if the participant has the diagnosis
This will be used in a subgroup of participants to confirm/rule out a diagnosis

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Inventory of Functional Status after Childbirth
Time Frame: one time between 6-10 weeks postpartum
Questionnaire used to measure a postpartum woman's ability to function within 5 different domains.
one time between 6-10 weeks postpartum

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Numeric Pain Scale
Time Frame: one time between 6-10 weeks postpartum
0-10 scale for the participant to identify any areas of pain in various regions of the body
one time between 6-10 weeks postpartum
Oswestry Low Back Pain Disability Index
Time Frame: one time between 6-10 weeks postpartum
A questionnaire to determine if the participant has any disability in the presence of low back pain
one time between 6-10 weeks postpartum
Pelvic Floor Distress Index
Time Frame: one time between 6-10 weeks postpartum
Questionnaire to determine if the participant has pelvic floor dysfunction
one time between 6-10 weeks postpartum

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

July 2, 2021

Primary Completion (ANTICIPATED)

May 1, 2023

Study Completion (ANTICIPATED)

May 1, 2023

Study Registration Dates

First Submitted

July 7, 2022

First Submitted That Met QC Criteria

January 23, 2023

First Posted (ACTUAL)

February 2, 2023

Study Record Updates

Last Update Posted (ACTUAL)

February 2, 2023

Last Update Submitted That Met QC Criteria

January 23, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • IRB-FY2021-405

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diastasis Recti

Clinical Trials on Self-palpation via telehealth

Subscribe